Robert K Zeldin's Net Worth
$742 Thousand
Who is Robert K Zeldin?
Robert K Zeldin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Health Sciences Acquisitions Corp, MeiraGTx Holdings plc, and ACCELERON PHARMA INC.
SEC CIK
Robert K Zeldin's CIK is 0001745347
Past Insider Trading and Trends
2022 was Robert K Zeldin's most active year for acquiring shares with 4 total transactions. Robert K Zeldin's most active month to acquire stocks was the month of December. 2024 was Robert K Zeldin's most active year for disposing of shares, totalling 5 transactions. Robert K Zeldin's most active month to dispose stocks was the month of December. 2022 saw Robert K Zeldin paying a total of $39,499.94 for 105,000 shares, this is the most they've acquired in one year. In 2023 Robert K Zeldin cashed out on 104,513 shares for a total of $206,295.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Health Sciences Acquisitions Corp (IMVT) Snapshot price: $34
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MeiraGTx Holdings plc (MGTX) Snapshot price: $3.88
CHIEF MEDICAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -16.11% | -13.77K |
$6.30 | -$86,769.90 | 71.71K |
Jan 7
| |||
Form 4
| +33.96% | 22.74K |
$6.36 | -$93,848.16 | 89.72K |
Jan 14 - Jan 17
| |||
Form 4
| +32.67% | 16.49K |
$6.30 | -$116,594.10 | 66.98K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +909.74% | 45.49K |
$6.99 | -$206,295.87 | 50.49K |
Jan 14
| |||
Form 4
|
∞
| 5K |
$7.90 | $39,499.94 | 5K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACCELERON PHARMA INC No price found
EVP & Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.02% | 2.2K |
—
|
—
| 19.1K |
Jan 25
| |||
Form 4
|
∞
| 16.9K |
—
|
—
| 16.9K |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||